The immunogenicity of MUC1 peptides and fusion protein
- 23 March 1995
- journal article
- clinical trial
- Published by Elsevier in Cancer Letters
- Vol. 90 (1) , 21-26
- https://doi.org/10.1016/0304-3835(94)03673-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Immune Responses of Mice and Human Breast Cancer Patients following Immunization with Synthetic Sialyl‐Tn Conjugated to KLH Plus Detox AdjuvantAnnals of the New York Academy of Sciences, 1993
- Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvantCancer Immunology, Immunotherapy, 1993
- Active Immunization of Human Ovarian Cancer Patients Against a Common Carcinoma (Thomsen-Friedenreich) Determinant Using a Synthetic Carbohydrate AntigenJournal of Immunotherapy, 1992
- Assignment of human tracheobronchial mucin gene(s) to 11p15 and a tracheobronchial mucin-related sequence to chromosome 13Human Genetics, 1990
- Molecular cloning of cDNAs derived from a novel human intestinal mucin geneBiochemical and Biophysical Research Communications, 1990
- A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomasInternational Journal of Cancer, 1989
- Molecular Cloning of Human Intestinal Mucin cDNAsJournal of Biological Chemistry, 1989
- A New Breast Carcinoma Antigen Defined by a Monoclonal Antibody2JNCI Journal of the National Cancer Institute, 1985